Procaterol

Procaterol

Procaterol is a beta-2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is classified as a short-acting beta-2 agonist (SABA) and is available in both oral and inhaled forms.

Pharmacology

Procaterol works by stimulating the beta-2 adrenergic receptors in the lungs, which causes the muscles in the airways to relax. This results in bronchodilation, or widening of the airways, which makes it easier for the patient to breathe. Procaterol is a selective agonist, meaning it primarily targets the beta-2 receptors in the lungs and has minimal effect on the beta-1 receptors in the heart.

Clinical Use

Procaterol is used to relieve the symptoms of asthma and COPD, including shortness of breath, wheezing, and chest tightness. It is typically used on an as-needed basis to treat acute symptoms, but can also be used regularly to prevent symptoms in patients with persistent asthma or COPD.

Side Effects

Common side effects of procaterol include tremor, nervousness, and headache. Less common but more serious side effects can include cardiac arrhythmia, hypokalemia, and hyperglycemia. Patients with a history of cardiovascular disease or diabetes should use procaterol with caution.

Interactions

Procaterol can interact with other medications, including other beta-2 agonists, beta blockers, and monoamine oxidase inhibitors. These interactions can increase the risk of side effects or decrease the effectiveness of procaterol.

See Also

• Beta-2 adrenergic receptor
• Asthma
• Chronic obstructive pulmonary disease
• Short-acting beta-2 agonist
• Selective agonist

‎